PNV - Polynovo Limited

[Dona Ferentes]

up 8% today
PolyNovo is excited to announce the approval of NovoSorb BTM by the Taiwan FDA for sale in Taiwan. PolyNovo said it has also contracted with Evermed, a Taiwan based distributor to sell BTM.

Managing Director, Paul Brennan said, “This is an exciting development for PolyNovo. Taiwan has an advanced health system and has a population of circa 23 million concentrated in three regions. The dermal matrix market in Taiwan has good potential for us in reconstructive surgery, trauma and burns.”

 

[Knobby22]

up 8% today
PolyNovo is excited to announce the approval of NovoSorb BTM by the Taiwan FDA for sale in Taiwan. PolyNovo said it has also contracted with Evermed, a Taiwan based distributor to sell BTM.


View attachment 113865

Don't want to curse it but Polynovo really seems to have hit a new stable level. Probably struggle to break $3 though in the near term.

 

[Dona Ferentes]

Don't want to curse it but Polynovo really seems to have hit a new stable level. Probably struggle to break $3 though in the near term.

made it to $4 , but then retreated. Today's update more +ve than -ve

Interim Trading Update
• H1 FY21 up 31% on H1 FY20
• Strong sales Q1 FY21 up 75% on Q1 FY20
• Slower than expected sales in October and November
• Strong December sales exceeded budget in US, NZ, and Taiwan

 

[Dona Ferentes]

Probably struggle to break $3 though in the near term.

Naw, punched through !!

Oops; wrong direction


(DNH)

 

[sptrawler]

Naw, punched through !!



Oops; wrong direction


(DNH)

What caused that Donna? Tinhat is very upbeat PNV, it may be a buying opportunity is presenting.

 

[finicky]

Still a $2.95 share price on 3 cents per share sales in fy20, what can go wrong? Get in while you've got the chance.
Imagine what the P/E will look like after first year that PNV makes a profit.
4c book value, so that's approx price to book = 74. How's that going to fare in a crash?

 

[Dona Ferentes]

tantalising. Impatience => sell down ??!

Managing Director, Paul Brennan said,

"In the short-term forecasting sales will be challenging particularly in the US, however the medium-term outlook is strong, and we continue to see surgeons using and referring NovoSorb BTM to their peers. Once hospitals have more capacity, we will see US and UK sales accelerate just as we have seen in New Zealand and Australia. New geographies offer good opportunities for NovoSorb BTM.”

 

[Knobby22]

Could get to $2.50 gain. Can't see it going lower than $2.30.

 

[galumay]

I can promise truly massive earnings growth, but you know the share market.

Let's agree to meet here again in January 2022 to see where PNV is at in terms of earnings, return on equity and share price then. I hold.

sounds like a plan, I will set a reminder and check back in.

1 year down in the 2 year challenge, still making a loss, the next 12 months will need to be amazing for this business to finally justify its share price!

 

[Trav.]

may be a buying opportunity is presenting.

I thought the same today and entered. It might be a risky trade but thought that I would have a go as it looked oversold on the chart. We will have to wait and see

Holding @ 2.80 with some momentum kicking back up......

 

[sptrawler]

I thought the same today and entered. It might be a risky trade but thought that I would have a go as it looked oversold on the chart. We will have to wait and see

Holding @ 2.80 with some momentum kicking back up......

Reading on their product it is interesting, I personally dont hold, but have long term horizons so it doesnt fit my portfolio.

 

[Knobby22]

I thought the same today and entered. It might be a risky trade but thought that I would have a go as it looked oversold on the chart. We will have to wait and see

Holding @ 2.80 with some momentum kicking back up......

View attachment 118441

I am getting interested after today. These sort of companies often overshoot.

 

[Trav.]

I am getting interested after today. These sort of companies often overshoot.

Yeah I got it wrong today but still in and will wait and see.

Same thought process with the oversold, but being a Friday didn't help

 

[Mickymouse]

I been buying and selling this company over a year can't believe it dropped to 2.52 today. The news a few days ago wasn't even that bad....

 

[Knobby22]

I been buying and selling this company over a year can't believe it dropped to 2.52 today. The news a few days ago wasn't even that bad....

I sold a few near the recent high but kept most of them. In hindsight I should of have sold more. I knew it had risen too fast a bit beyond fundzmentals but was too gutless to sell more.

Share prices have momentum, once they start moving in a direction, they tend to have trouble stopping.

Will be buying back what I sold.

 

[Trav.]

and Trav breathes a sigh of relief

 

[barney]

and Trav breathes a sigh of relief

Hopefully on the way back

Positive news.

Poland Distributor
Turkey Distributor

 

[UMike]

Did you end up buying some @tinhat ?

I am seriously looking at this more for a buy and hold than spec trade.

 

[peter2]

I agree, PNV is an interesting reversal opportunity. It's hard to overlook the impulsive selloff. The top half of the selloff could have been profit taking but then after their latest H1 FY21 update the selloff quickened with huge volume. There's no clear selling climax but price has certainly settled in this tight range. The market may need more time.

I'd be waiting for some indication that demand is rising like a close above 2.75 with above average volume. If price falls below 2.40 then I'd discard the chart until it appeared in a daily/weekly bullish bar scan.

 

[UMike]

Tipped this in the Monthly.
With the new product on the way and directors buying there may be a positive announcement coming soon.